Biologics Regulatory Spine Top Stories Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures byJosh SandbergOctober 12, 2023
Biologics Financial Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform byJosh SandbergJuly 6, 2023
Biologics Spine Top Stories PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery byJosh SandbergApril 6, 2023
Biologics Regulatory Spine Ventris Medical Receives 510(k) Clearance for Amplify® Standalone Bone Graft Putty and Bone Graft Extender byJosh SandbergSeptember 14, 2022
Biologics Spine Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures byChris StewartFebruary 22, 2022
Biologics Spine Orthofix Launches O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK byChris StewartOctober 7, 2020
Biologics Extremities OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™ byChris StewartDecember 20, 2019
Extremities Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI) byJosh SandbergDecember 16, 2019
Extremities Cartiva, Inc. Announces First US Procedure for FDA Approved Cartiva Synthetic Cartilage Implant byJosh SandbergJuly 12, 2016
Hospitals Cartiva, Inc. Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant byJosh SandbergJuly 6, 2016
